Company Spotlight features video, webcasts, presentations and annual reports for more than 30,000 companies. Sign up to promote your company. ×
iCo Therapeutics, Inc.
Pharmaceutical Preparations Canada
OTC Bulletin Board: ICOTF | TSX Venture Exchange: ICO
Company Description
iCo Therapeutics, Inc. is a biotechnology company. It focuses on the identification, development and commercialization of drug candidates that treat sight and life threatening diseases through a development-only business model. Its strategy is to in-license, reprofile or reposition drug candidates that have clinical or pre-clinical history and compelling evidence of scientific, clinical and commercial potential in ocular and other disease indications. The company has in-licensed three product candidates: iCo-007, iCo-008 (also known as Bertilimumab) and an oral Amphotericin B delivery system, (Oral AmpB Delivery System) (formerly known as iCo-009) that it believe have the potential to treat sight threatening and life threatening conditions. iCo Therapeutics was founded by Andrew J. Rae, John G. Clement and William John Meekison on February 15, 2005 and is headquartered in Vancouver, Canada.
Similar to: Columbia Laboratories, Inc., BioGaia AB, NPS Pharmaceuticals, Inc.
Featured Company
Alexco Resource Corp.
Vancouver, BC, CA
Canadas Only Primary Silver Producer Alexco owns and operates the Bellekeno silver mine, Canadas only operating primary silver… Learn more →
You may also be interested in:
NPS Pharmaceuticals, Inc.
Bedminster, NJ, US
NPS Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs… Learn more →
BioGaia AB
Stockholm, SE
BioGaia develops, markets and sells probiotic products with documented health benefits. Its products are primarily based on different… Learn more →
Columbia Laboratories, Inc.
Livingston, NJ, US
Columbia Laboratories, Inc. develops, manufactures and sells pharmaceutical products. Its pharmaceutical products include CRINONE… Learn more →